Abstract: The invention encompasses therapeutic formulations comprising a protein active ingredient and a stabilizing excipient, methods of improving stability in a therapeutic formulation comprising a protein active ingredient by adding a stability-improving amount of a stabilizing excipient to the therapeutic formulation, and methods of reducing adverse infusion-related effects in a patient, comprising administering to a patient in need thereof a therapeutic formulation comprising a protein active ingredient and a stabilizing excipient.
Type:
Grant
Filed:
March 15, 2019
Date of Patent:
April 7, 2020
Assignee:
REFORM BIOLOGIES, LLC
Inventors:
David S. Soane, Robert P. Mahoney, Philip Wuthrich, Daniel G. Greene